Skip to content
Clinical Trial Events
LSX Investival Showcase London 2026

Panel Headliner Stage track

Breaking Barriers: Cross-Border Licensing and Deal-Making in China

Mon, Nov 16, 2026 · 11:15 AM–12:00 PM GMT Old Billingsgate

About this session

China’s dynamic market offers immense opportunities for cross-border licensing and partnerships, but navigating its unique regulatory, cultural, and commercial landscape requires strategic finesse. This panel brings together pharma leaders, startup innovators, and investors to share actionable insights on overcoming challenges and unlocking the full potential of China’s licensing ecosystem How to structure cross-border licensing deals that balance risk, reward, and long-term value Navigating China’s evolving regulatory environment and data protection laws to ensure compliance and efficiency…

Speakers

  • Sadiqa Mahmood

    Founder & CEO · Prudentia Sciences

    Moderator

  • Debra Yu

    COO & Partner · Panacea Capital

    Panelist

  • Wei Peng

    Co-Founder & Chief Business Officer · Crimson Gateway

    Panelist

  • Philip Coxon

    Executive Director, Business Development · Insmed

    Panelist

  • Lydia Torne

    Partner · Latham & Watkins

    Panelist

  • Austin Doyle

    Executive Director, Business Development Transactions · GSK

    Panelist